PHAR vs PHG: Side-by-Side Comparison
Compare Pharming Group N.V. (PHAR) and Koninklijke Philips N.V. (PHG) side by side: market cap USD 965.83M vs USD 26.41B, P/E 79.9 vs 23.8. Financials, growth and model signals on Bullrun.
| Metric | PHAR | PHG |
|---|---|---|
| Company | Pharming Group N.V. | Koninklijke Philips N.V. |
| Country / Exchange | Netherlands · NASDAQ | Netherlands · NYSE |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Medical Devices |
| Market cap | USD 965.83M | USD 26.41B |
| P/E ratio | 79.9 | 23.8 |
| Dividend yield | — | 3.65% |
| Valuation model | 37.6% overvalued | 10.4% undervalued |
| Revenue (latest FY) | — | — |
| Revenue growth YoY | — | — |
| Net income | — | — |
| Gross margin | — | — |
| Diluted EPS | — | — |